BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 28522033)

  • 1. Placenta-directed gene therapy for fetal growth restriction.
    Krishnan T; David AL
    Semin Fetal Neonatal Med; 2017 Dec; 22(6):415-422. PubMed ID: 28522033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maternal uterine artery VEGF gene therapy for treatment of intrauterine growth restriction.
    David AL
    Placenta; 2017 Nov; 59 Suppl 1():S44-S50. PubMed ID: 29031540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Vitro Human Placental Studies to Support Adenovirus-Mediated VEGF-D
    Desforges M; Rogue A; Pearson N; Rossi C; Olearo E; Forster R; Lees M; Sebire NJ; Greenwood SL; Sibley CP; David AL; Brownbill P
    Hum Gene Ther Clin Dev; 2018 Mar; 29(1):10-23. PubMed ID: 29228803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uteroplacental adenovirus vascular endothelial growth factor gene therapy increases fetal growth velocity in growth-restricted sheep pregnancies.
    Carr DJ; Wallace JM; Aitken RP; Milne JS; Mehta V; Martin JF; Zachary IC; Peebles DM; David AL
    Hum Gene Ther; 2014 Apr; 25(4):375-84. PubMed ID: 24593228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perinatal and long-term effects of maternal uterine artery adenoviral VEGF-A165 gene therapy in the growth-restricted guinea pig fetus.
    Vaughan OR; Rossi CA; Ginsberg Y; White A; Hristova M; Sebire NJ; Martin J; Zachary IC; Peebles DM; David AL
    Am J Physiol Regul Integr Comp Physiol; 2018 Aug; 315(2):R344-R353. PubMed ID: 29847165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between transplacental O2 diffusion and placental expression of PlGF, VEGF and their receptors in a placental insufficiency model of fetal growth restriction.
    Regnault TR; de Vrijer B; Galan HL; Davidsen ML; Trembler KA; Battaglia FC; Wilkening RB; Anthony RV
    J Physiol; 2003 Jul; 550(Pt 2):641-56. PubMed ID: 12740423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin-like growth factor 1 signaling in the placenta requires endothelial nitric oxide synthase to support trophoblast function and normal fetal growth.
    Wilson RL; Troja W; Sumser EK; Maupin A; Lampe K; Jones HN
    Am J Physiol Regul Integr Comp Physiol; 2021 May; 320(5):R653-R662. PubMed ID: 33621475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ethics and social acceptability of a proposed clinical trial using maternal gene therapy to treat severe early-onset fetal growth restriction.
    Sheppard M; Spencer RN; Ashcroft R; David AL;
    Ultrasound Obstet Gynecol; 2016 Apr; 47(4):484-91. PubMed ID: 26968870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pregnancy outcome and placental findings in pregnancies complicated by fetal growth restriction with and without preeclampsia.
    Kovo M; Schreiber L; Elyashiv O; Ben-Haroush A; Abraham G; Bar J
    Reprod Sci; 2015 Mar; 22(3):316-21. PubMed ID: 25001023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraplacental gene therapy with Ad-IGF-1 corrects naturally occurring rabbit model of intrauterine growth restriction.
    Keswani SG; Balaji S; Katz AB; King A; Omar K; Habli M; Klanke C; Crombleholme TM
    Hum Gene Ther; 2015 Mar; 26(3):172-82. PubMed ID: 25738403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of placental neuropilin-1 in fetal growth restriction.
    Maulik D; De A; Ragolia L; Evans J; Grigoryev D; Lankachandra K; Mundy D; Muscat J; Gerkovich MM; Ye SQ
    Am J Obstet Gynecol; 2016 Feb; 214(2):279.e1-279.e9. PubMed ID: 26409917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Placental nanoparticle gene therapy normalizes gene expression changes in the fetal liver associated with fetal growth restriction in a fetal sex-specific manner.
    Wilson RL; Stephens KK; Jones HN
    J Dev Orig Health Dis; 2023 Jun; 14(3):325-332. PubMed ID: 36794386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FIGO (international Federation of Gynecology and obstetrics) initiative on fetal growth: best practice advice for screening, diagnosis, and management of fetal growth restriction.
    Melamed N; Baschat A; Yinon Y; Athanasiadis A; Mecacci F; Figueras F; Berghella V; Nazareth A; Tahlak M; McIntyre HD; Da Silva Costa F; Kihara AB; Hadar E; McAuliffe F; Hanson M; Ma RC; Gooden R; Sheiner E; Kapur A; Divakar H; Ayres-de-Campos D; Hiersch L; Poon LC; Kingdom J; Romero R; Hod M
    Int J Gynaecol Obstet; 2021 Mar; 152 Suppl 1(Suppl 1):3-57. PubMed ID: 33740264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanoparticle-mediated transgene expression of insulin-like growth factor 1 in the growth restricted guinea pig placenta increases placenta nutrient transporter expression and fetal glucose concentrations.
    Wilson RL; Lampe K; Gupta MK; Duvall CL; Jones HN
    Mol Reprod Dev; 2022 Nov; 89(11):540-553. PubMed ID: 36094907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and management of fetal growth restriction: the role of fetal therapy.
    Hui L; Challis D
    Best Pract Res Clin Obstet Gynaecol; 2008 Feb; 22(1):139-58. PubMed ID: 17698415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in interleukin-6 and IGF system and their relationships in placenta and cord blood in newborns with fetal growth restriction compared with controls.
    Street ME; Seghini P; Fieni S; Ziveri MA; Volta C; Martorana D; Viani I; Gramellini D; Bernasconi S
    Eur J Endocrinol; 2006 Oct; 155(4):567-74. PubMed ID: 16990656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of soluble vascular endothelial growth factor receptor-1 and placental growth factor in fetal growth restriction cases and intervention effect of tetramethylpyrazine.
    Li SW; Ling Y; Jin S; Lin YF; Chen ZJ; Hu CX; Wang MH; Yao MZ
    Asian Pac J Trop Med; 2014 Aug; 7(8):663-667. PubMed ID: 25149383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does Vascular Endothelial Growth Factor Gene Therapy Safely Improve Outcome in Severe Early-Onset Fetal Growth Restriction? (EVERREST).
    Hum Gene Ther Clin Dev; 2015 Jun; 26(2):82-4. PubMed ID: 26086754
    [No Abstract]   [Full Text] [Related]  

  • 19. Identifying late-onset fetal growth restriction by measuring circulating placental RNA in the maternal blood at 28 weeks' gestation.
    Whitehead CL; McNamara H; Walker SP; Alexiadis M; Fuller PJ; Vickers DK; Hannan NJ; Hastie R; Tuohey L; Kaitu'u-Lino TJ; Tong S
    Am J Obstet Gynecol; 2016 Apr; 214(4):521.e1-521.e8. PubMed ID: 26880734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peri- and Postnatal Effects of Prenatal Adenoviral VEGF Gene Therapy in Growth-Restricted Sheep.
    Carr DJ; Wallace JM; Aitken RP; Milne JS; Martin JF; Zachary IC; Peebles DM; David AL
    Biol Reprod; 2016 Jun; 94(6):142. PubMed ID: 27103444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.